-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PC8z+P+OSLnwRg6sQm+jx2KxfmXOwMDMstsIuhSU8Lv+qRJQB6Kter4StjlBLSF1 IjYUnMXQNQjyql0Dt0vcWA== 0001237899-11-000013.txt : 20110119 0001237899-11-000013.hdr.sgml : 20110119 20110119170946 ACCESSION NUMBER: 0001237899-11-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110118 FILED AS OF DATE: 20110119 DATE AS OF CHANGE: 20110119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Van Plew Daniel P CENTRAL INDEX KEY: 0001411984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 11536358 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2011-01-18 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001411984 Van Plew Daniel P 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP & GM, Indust Ops&Prod Supp Common Stock 2011-01-18 4 M 0 10000 21.92 A 10000 D Common Stock 2011-01-18 4 S 0 10000 35.22 D 0 D Common Stock 2011-01-18 4 M 0 15000 20.9 A 15000 D Common Stock 2011-01-18 4 S 0 15000 35.22 D 0 D Common Stock 881 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 20.9 2011-01-18 4 M 0 15000 D 2017-09-07 Common Stock 15000 30432 D Non-Qualified Stock Option (right to buy) 21.92 2011-01-18 4 M 0 10000 D 2017-12-17 Common Stock 10000 30000 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Daniel P. Van Plew 2011-01-19 -----END PRIVACY-ENHANCED MESSAGE-----